Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of vaping on the health of pregnant women; and whether she plans to take steps to encourage pregnant women to stop vaping.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Our health advice on vaping is clear, if you smoke, it is better to vape, but if you don’t smoke, you should never vape. Evidence to date suggests vaping is less harmful than smoking. Research funded by the National Institute for Health and Care Research finds that pregnant women who vaped, when compared to women who used Nicotine Replacement Therapy, were twice as likely to quit, and that both approaches were safer than smoking. Further information is available at the following link:
https://www.nature.com/articles/s41591-022-01808-0
To help pregnant smokers quit smoking, the Government is providing up to £10 million of investment over 2023/24 and 2024/25 via a financial incentives scheme. This evidence-based intervention, supported by behavioural support, will encourage pregnant women to quit smoking, and remain smokefree throughout pregnancy and beyond, helping to improve the health and wellbeing of both mother and baby.
Asked by: Helen Grant (Conservative - Maidstone and The Weald)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent progress she has made on retaining more GPs.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
There were 2,799 more full time equivalent (FTE) doctors working in general practice (GP) in December 2023, compared to December 2019. The Government is working with NHS England to increase the GP workforce in England. This includes measures to boost recruitment, address the reasons why doctors leave the profession, and encourage them to return to practice. NHS England has made available a number of retention schemes, to boost the GP workforce.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government, with reference to declining immunisation rates in the UK, what level of prioritisation the Department of Health and Social Care and the UK Health Security Agency are giving to the adoption of new immunisation programmes with high uptake.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The introduction and adoption of new immunisation programmes and achieving high uptake across all immunisation programmes remains a high priority for the Government. We achieve high uptake for both life-course and seasonal vaccinations, with over 90% for pre-school diphtheria, tetanus, and pertussis and among the highest in the world for flu vaccination. The NHS COVID-19 vaccination programme has been the biggest vaccine drive in the history of the National Health Service, implementing the largest volume of new vaccines in the shortest time, and repeatedly with boosters. 157.5 million COVID-19 vaccinations were delivered in England from December 2020 to the end of January 2024. However, over the last decade, performance across routine immunisation programmes has been in decline and continued variation in uptake and coverage between different communities reflects wider health inequalities.
In response to these challenges, the NHS vaccination strategy builds on lessons learnt from the pandemic and the success of our routine immunisation programmes. It aims to maximise uptake and coverage of vaccinations across all communities, improving uptake to save more lives.
Asked by: Baroness Jones of Moulsecoomb (Green Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure that the proposed WHO Pandemic Preparedness Treaty, due to be considered by the 77th World Health Assembly in May, will include provisions to improve indoor air quality.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The United Kingdom welcomes the Pandemic Accord as an opportunity to strengthen global health security. Improving indoor air quality remains an important issue in public health. However, as the Accord aims to establish a high-level framework for pandemic prevention, preparedness and response, we have pursued action on this specific issue in other multilateral settings.
The UK continues to support international improvements to indoor air pollution through its engagement with the World Health Organization (WHO). For example, the UK Health Security Agency (UKHSA) contributed to WHO projects in 2020 and 2022 to assess combined exposure to multiple chemicals in indoor air in schools. UKHSA continues to work with the International Society on Indoor Air Quality and Climate on the development of an open database on international indoor environmental quality guidelines. The database aims to be actively used by researchers, practitioners, and policymakers across the world.
Moreover, the UK was a strong advocate for action to improve indoor air quality at last year’s United Nations General Assembly. We worked with international partners on this issue during the High-Level Meeting on Universal Health Coverage. The UK was supportive of reference being made to the health impacts of indoor air pollution, which was subsequently adopted in the meeting’s political declaration on 5 October 2023, and is available on the United Nations website in an online-only format.
Asked by: Baroness Jenkin of Kennington (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government, following the Food Data Transparency Partnership’s decision not to make reporting on health data mandatory, what steps they are taking to ensure enforcement of and consistency in the voluntary scheme.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Food Data Transparency Partnership’s (FDTP) Health Working Group (HWG) has been testing the effectiveness and quality of potential standardised metrics that food and drink companies can use to report on the healthiness of their sales. This is an important part of government’s strategy to address poor diet and reduce obesity and was restated in the Major Conditions Strategy interim report August 2023.
Once a recommended set of metrics and reporting guidance has been produced and approved by Ministers, the expectation is that businesses who voluntarily report will all follow this standardised approach.
A key commitment of the HWG is timely and transparent communication so that wider food sector stakeholders can input into each stage of the process in order to ensure recommendations around comparability and enforcement will be as viable and effective as possible. Alongside engagement with industry, the FDTP also regularly engages civil society organisations and investor groups to gather and integrate wider feedback into discussions. Summaries of these HWG discussions are published online on the FDTP GOV.UK page.
Asked by: Keir Mather (Labour - Selby and Ainsty)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the potential merits of adding medications related to (a) asthma and (b) chronic obstructive pulmonary disease to the NHS prescription charge exemption list.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
While the Government’s policy remains, that there are no plans to review the list of medical conditions that entitle someone to apply for a medical exemption certificate, there are extensive arrangements currently in place in England to ensure that prescriptions are affordable for everyone, including for those with asthma and chronic obstructive pulmonary disease.
Approximately 89% of prescription items are dispensed free of charge in the community in England, and there is a wide range of exemptions from prescription charges already in place for which those with heart disease may be eligible. Eligibility depends on the patient’s age, whether they are in qualifying full-time education, whether they are pregnant or have recently given birth, or whether they are in receipt of certain benefits or a war pension.
People on a low income can apply for help with their health costs through the NHS Low Income Scheme. The scheme provides income related help to people who are not automatically exempt from charges, but who may be entitled to full or partial help if they have a low income and savings below a defined limit.
To support those with greatest need who do not qualify for an exemption or the NHS Low Income Scheme, Prescription Prepayment Certificates (PPCs) are available. PPCs allow people to claim as many prescriptions as they need for a set cost, with three month and 12 month certificates available, which can be paid for in instalments.
Asked by: Tonia Antoniazzi (Labour - Gower)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential impact of increased rates of breastfeeding on cost savings for the NHS.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
The public health benefits of breastfeeding for child and maternal health are significant and well established. Research published in the British Medical Journal suggests that increasing breastfeeding rates, both in terms of duration and exclusivity, is likely to generate substantial cost savings to the National Health Service, although the actual amounts saved will depend on the extent of this increase.
Through the Family Hubs and Start for Life Programme, we are investing £50 million to increase the range of specialist support, which is enabling more parents to access face-to-face and virtual support whenever they need it. One of the objectives of the programme is to improve the evidence base around the impact of breastfeeding interventions, and the specific combination of interventions that are effective in different circumstances. This is expected to strengthen the case for further, more widespread investment in the future.
Asked by: Preet Kaur Gill (Labour (Co-op) - Birmingham, Edgbaston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many NHS Inpatient Detox units there are by location.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
There are eight NHS inpatient detoxification units in England. They are listed below:
Guys and St Thomas NHS Trust (London),
Bridge House, Kent and Medway NHS Trust (Maidstone, Kent),
Dame Carol Black Unit, Midlands Foundation NHS Trust (Fareham, Hampshire),
Acer Unit, Avon & Wiltshire Mental Health Partnership NHS Trust (Bristol),
Edward Myers Unit, Staffordshire Combined NHS Trust (Stoke),
New Beginnings, Rotherham, Doncaster, South Humber Foundation NHS Trust (Doncaster), Chapman Barker Unit, Greater Manchester Mental Health NHS Trust (Manchester),
Topaz Ward, Essex Partnership NHS Trust (Chelmsford, Essex).
Asked by: Bell Ribeiro-Addy (Labour - Streatham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help support (a) hospice and (b) other end-of-life services.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
As part of the Health and Care Act 2022, the Government added palliative care services to the list of services an integrated care board (ICB) must commission, promoting a more consistent national approach, and supporting commissioners in prioritising palliative and end of life care.
The majority of palliative and end of life care is provided by National Health Service staff and services. However, we also recognise the vital part that voluntary sector organisations, including hospices, play in providing support to people at end of life, and their families. Most hospices are charitable, independent organisations which receive some statutory funding for providing NHS services. The amount of funding hospices receive is dependent on many factors, including what other statutory services are available within the ICB footprint. Charitable hospices provide a range of services which go beyond that which statutory services are legally required to provide, and consequently, the funding arrangements reflect this.
To support ICBs, NHS England has published statutory guidance and service specifications for both adults and children. NHS England has also commissioned the development of a palliative and end of life care dashboard, which brings together relevant, all age local data in one place. The dashboard helps commissioners understand the palliative and end of life care needs of both adults and children in their local population, enabling ICBs to put plans in place to address and track the improvement of health inequalities.
NHS England has also funded seven strategic clinical networks for palliative and end of life care. These networks support commissioners in the delivery of outstanding clinical and personalised care for people in the last years of life, and reduce local variation.
At a national level, NHS England has confirmed it will renew the Children and Young People’s hospice funding for 2024/25, again allocating £25 million of grant funding for children’s hospices, using the same prevalence-based allocation approach as in 2022/23 and 2023/24. The Government has provided £60 million of additional funding to help deliver the one-off payments to over 27,000 eligible staff employed on dynamically linked Agenda for Change contracts by non-NHS organisations, including some hospices.
Asked by: Yasmin Qureshi (Labour - Bolton South East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make it her policy to commission an independent review of the Commission on Human Medicines’ Expert Working Group’s report on Hormone Pregnancy Tests.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
We remain hugely sympathetic to the families who believe that they have suffered as a result of using Hormone Pregnancy Tests. We have no plans to set up an independent review to examine the findings of the Expert Working Group. In the interests of transparency, all evidence collected and papers considered by the Expert Working Group were published in 2018, along with full minutes of its discussions. Details of conflicts of interests, and how these were managed, were also published.